In a previously published study, we observed that among the 13 breast cancer individuals with positive germline pathogenic variant findings, the majority had variants in the BRCA1/2 genes, while the remaining individuals had variants in other high- or moderate-risk genes, such as PALB2, TP53, ATM, and CHEK2 [2]. This evidence concerns the gene TP53 and breast cancer.